Form 4: Sight Sciences Executive Receives 96,000 Restricted Stock Units
SEC Form 4 Filing
Manohar K. Raheja, EVP of Research & Development at Sight Sciences, was granted 96,000 restricted stock units (RSUs) under the company's 2021 Incentive Award Plan.
Summary
- Manohar K. Raheja, the EVP of Research & Development at Sight Sciences, received a grant of 96,000 restricted stock units (RSUs).
- These RSUs were granted under the company's 2021 Incentive Award Plan.
- The RSUs will vest in four equal annual installments starting on November 15, 2025, and continuing through November 15, 2028.
- Vesting is contingent upon Mr. Raheja's continued employment with Sight Sciences through each vesting date.
- Each RSU represents the right to receive one share of Sight Sciences' common stock, with a par value of $0.001 per share.
- The RSUs have no expiration date.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns executive interests with company performance. There are no negative implications.
Positives
- The grant of RSUs aligns the executive's interests with the long-term performance of the company.
- The vesting schedule encourages continued service and commitment from the executive.
Risks
- The value of the RSUs is dependent on the future stock price of Sight Sciences, which is subject to market fluctuations.
Future Outlook
The vesting of the RSUs is contingent on the executive's continued service to the company through each vesting date.
Industry Context
The granting of stock-based compensation is a common practice in the technology and biotechnology industries to attract and retain key talent.
Comparison to Industry Standards
- Stock-based compensation, such as RSUs, is a standard practice for executive compensation in publicly traded companies, particularly in the tech and biotech sectors.
- The vesting schedule of four years is also a common practice to ensure long-term commitment from executives.
- Companies like Alcon, Johnson & Johnson Vision, and Bausch + Lomb also use similar compensation strategies for their executives.
Stakeholder Impact
- The RSU grant may have a minor positive impact on shareholder sentiment as it incentivizes executive performance.
- The executive is incentivized to remain with the company, which benefits employees and other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 11/12/2024 | Date of the RSU grant. |
| 11/15/2025 | First vesting date for the RSUs. |
| 11/15/2028 | Final vesting date for the RSUs. |
| 11/18/2024 | Date of the filing. |
Keywords
restricted stock units, RSUs, stock grant, executive compensation, incentive award plan, Sight Sciences, Manohar Raheja
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.